American Patients First Act of 2026
To amend title XVIII of the Social Security Act to adjust payment for skin substitute products under the Medicare program.
HB9972, also known as the American Patients First Act of 2026, aims to change how the Medicare program pays for certain skin substitute products. These products are used to treat severe wounds. If passed, the bill would adjust the payment rates for these medical items under Medicare, potentially affecting how much healthcare providers and patients pay or are reimbursed for these treatments.
The bill would mainly impact Medicare beneficiaries, healthcare providers, and medical suppliers who deal with skin substitute products. By adjusting the payment rates, the bill seeks to improve access and affordability for patients who need these treatments, while also ensuring that providers are fairly compensated for their services.
HB9972 was introduced on July 27, 2026, and has been referred to the Committee on Energy and Commerce and the Committee on Ways and Means for further review. The bill is currently in its initial stages and has not yet advanced to a vote or further consideration. Key actions include its introduction and referral to the appropriate committees for evaluation.
